ELL Antikörper (AA 350-450)
Kurzübersicht für ELL Antikörper (AA 350-450) (ABIN7266923)
Target
Alle ELL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 350-450
-
Verwendungszweck
- ELL Rabbit pAb
-
Sequenz
- PAVNGKLGVP NGREALLPTP GPPASTDTLS SSTHLPPRLE PPRAHDPLAD VSNDLGHSGR DCEHGEAAAP APTVRLGLPL LTDCAQPSRP HGSPSRSKPK K
-
Kreuzreaktivität
- Maus
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- A synthetic peptide corresponding to a sequence within amino acids 350-450 of human ELL (NP_006523.1).
-
Isotyp
- IgG
-
-
anti-Elongation Factor RNA Polymerase II (ELL) (Internal Region) antibody
ELL Reaktivität: Human, Maus WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 551-600) antibodyELL Reaktivität: Human, Maus, Hund, Ratte, Rind (Kuh), Pferd, Zebrafisch (Danio rerio), Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL Reaktivität: Human, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) antibodyELL Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 516-545), (C-Term) antibodyELL Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB23401 unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 522-619) antibodyELL Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 431-480) antibodyELL Reaktivität: Human, Hund WB Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL Reaktivität: Human, Maus, Hund, Ratte, Rind (Kuh), Meerschweinchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (C-Term) antibodyELL Reaktivität: Human, Maus, Hund, Ratte, Rind (Kuh), Pferd, Meerschweinchen, Zebrafisch (Danio rerio) WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (Middle Region) antibodyELL Reaktivität: Human, Hund WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Andere Bezeichnung
- ELL
-
Hintergrund
- Elongation factor component of the super elongation complex (SEC, a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Elongation factor component of the little elongation complex (LEC, a complex required to regulate small nuclear RNA (snRNA gene transcription by RNA polymerase II and III. Specifically required for stimulating the elongation step of RNA polymerase II- and III-dependent snRNA gene transcription. ELL also plays an early role before its assembly into in the SEC complex by stabilizing RNA polymerase II recruitment/initiation and entry into the pause site. Required to stabilize the pre-initiation complex and early elongation.,ELL,C19orf17,ELL1,MEN,PPP1R68,Epigenetics & Nuclear Signaling,Cancer,ELL
-
Molekulargewicht
- 68kDa
-
Gen-ID
- 8178
-
UniProt
- P55199
Target
-
